OKYO Pharma, Ltd.

We are a pre-clinical biopharmaceutical company developing next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases and ocular pain. Our research program is focused on a novel G Protein-Coupled Receptor, or GPCR, which we believe plays a key role in the pathology of these inflammatory eye diseases of high unmet medical […]

March 5, 2022 Read More

Visionary Education Technology Holdings Group

Our mission is to broaden access to the multicultural education system of Canada through advanced management and technological innovation and to facilitate the achievement of a student’s full potential regardless of social or immigration status. We are a licensed provider of private online and in person educational programs and services in Canada, serving both Canadian […]

March 4, 2022 Read More

AN2 Therapeutics, Inc.

We are a clinical-stage biopharmaceutical company developing treatments for rare, chronic and serious infectious diseases with high unmet needs. Our initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease. Epetraborole has broad spectrum antimycobacterial activity through inhibition of an essential and universal step in bacterial protein synthesis. […]

Read More

Hanover Bancorp, Inc./NY

In 2016, we became the holding company for Hanover Community Bank (“the Bank”), a New York-chartered community commercial bank. The bank was originally organized in 2009, with a focus on serving the South Asian community in Nassau County. After incurring financial and regulatory setbacks, the bank was recapitalized in 2012 by a group led by our […]

Read More

Denali Capital Acquisition

We intend to focus on the technology, hospitality and consumer services sectors. We will not complete our initial business combination with a target that is headquartered in China (including Hong Kong and Macau) or that conducts a majority of its business in China (including Hong Kong and Macau). (Incorporated in the Cayman Islands)  Our CEO […]

March 1, 2022 Read More

Makara Strategic Acquisition Corp.

(Note: Makara Strategic Acquisition Corp. withdrew its SPAC IPO in an SEC filing dated May 15, 2023. The company filed its S-1 on Feb. 28, 2022.) We intend to focus our search for a target business in the natural resources, clean energy or energy storage sectors in the Americas, Europe or Asia. Dr. Amin Badr-El-Din is […]

February 28, 2022 Read More

Giant Oak Acquisition Corp.

We are a blank check company incorporated in the British Virgin Islands. We will primarily seek to acquire one or more growth businesses with a total enterprise value of between $300 million and $600 million. We believe that there are a substantial number of potential target businesses within this valuation range that can benefit from […]

February 25, 2022 Read More

Haymaker Acquisition Corp. IV

(Note: Haymaker Acquisition Corp. IV withdrew its SPAC IPO plans in an SEC filing dated Dec. 13, 2022.) We intend to acquire and operate a business in the consumer and consumer-related products and services industries and believe our management team is well suited to identify opportunities that have the potential to generate attractive risk-adjusted returns for our […]

Read More

Lakeview Acquisition Corp.

(Note: Lakeview Acquisition Corp. withdrew its SPAC IPO plans in an SEC filing dated Dec. 27, 2022.) We intend to focus our search on target businesses in the insurance sector in the United States.

Read More

JAWS Wildcat Acquisition Corp.

We intend to focus our efforts on consumer technology and related technology businesses with either all or a substantial portion of its activities in North America and/or Europe. (Incorporated in the Cayman Islands)  Barry Sternlicht, the founder, chairman and CEO of Starwood Capital, and Matthew Walters, who previously spent his entire career with L Catterton, […]

February 23, 2022 Read More